Superficial Siderosis in Patients With Suspected Cerebral Amyloid Angiopathy "SuSPect-CAA"
Active, not recruiting
Phase N/A Results N/ASummary of Purpose
Aim of the SuSPect-CAA study is to prospectively evaluate the prognostic significance of cortical superficial siderosis in patients with suspected cerebral amyloid angiopathy with a primary focus on future stroke and mortality.
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 9 August 2017.
1 May 2013 | 15 May 2013 | 1 Dec 2018 | 1 May 2019 | 1 Aug 2017 | Unavailable |
Start Date | First Received | 1st Completion | Completion | Verification | Results |
---|
Trial Basics
Conditions
Sponsors
Trial Design
- Observation: Case Control
- Perspective: Prospective
- Sampling: Non-Probability Sample
Contacts
- Christian Opherk, MD
christian.opherk@med.uni-muenchen.de +49-89-7095
- Jennifer Linn, MD
View Trial Locations
Recruitment
- Enrollment: 302
- Gender: All
- Minimum Age: 55 Years
- Accepts Healthy Volunteers: No
- 1 location, 1 country
Principal Investigators
- Martin Dichgans, MD
martin.dichgans@med.uni-muenchen.de +49 (0)89 7095 Ext. 8310
- Christian Opherk, MD
christian.opherk@med.uni-muenchen.de +49-89-7095
- Jennifer Linn, MD